Silk Road Medical, Inc
Silk Road Medical, Inc., a pioneering medical device company headquartered in the United States, focuses on innovative solutions for carotid artery disease. Founded in 2007, the company has made significant strides in the vascular intervention industry, particularly with its flagship product, the ENROUTE Transcarotid Neuroprotection System. This unique system enhances patient safety during carotid artery procedures, setting Silk Road Medical apart in a competitive market.
With a strong presence in North America and expanding operations in Europe, Silk Road Medical has established itself as a leader in the field of neuroprotection and minimally invasive vascular interventions. The company’s commitment to advancing patient care is reflected in its notable achievements, including FDA approvals and recognition for its contributions to improving surgical outcomes.
+25 vs industry average
Silk Road Medical, Inc’s score of 52 is higher than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Silk Road Medical, Inc?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Medical Device Manufacturing has typical carbon intensity
Industry performance
The Medical Device Manufacturing industry has reduced its overall emissions by 18% since 2019
Emissions trajectory 2020 – 2026
Reported emissions
Scope 3 accounts for ••• of total emissions.
Silk Road Medical, Inc's reported carbon emissions
In 2023, Silk Road Medical, Inc. reported total emissions of approximately 792,900 kg CO2e, comprising 205,000 kg CO2e from Scope 1 and 587,900 kg CO2e from Scope 2 emissions. This reflects a decrease from 2022, where total emissions were approximately 891,000 kg CO2e, with Scope 1 at 290,000 kg CO2e and Scope 2 at 601,000 kg CO2e. The company has not disclosed any Scope 3 emissions data, indicating a gap in their reporting. Silk Road Medical, Inc. is a current subsidiary of Boston Scientific Corporation, which may influence its climate commitments and reporting practices. However, there are no specific reduction targets or climate pledges documented for Silk Road Medical, indicating a potential area for improvement in their sustainability strategy. The absence of disclosed reduction initiatives suggests that the company may need to enhance its climate action framework to align with industry standards and expectations.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Silk Road Medical, Inc’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Silk Road Medical, Inc yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
Inherited from Boston Scientific Corporation
Carbon Disclosure Project
Inherited from Boston Scientific Corporation
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisations
Silk Road Medical, Inc
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project